These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2860059)

  • 1. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 2. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population.
    Lau RC
    N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F; Fournier JM; Alouf JE
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and histopathology of pertussis: implications for immunization.
    Cherry JD; Paddock CD
    Expert Rev Vaccines; 2014 Sep; 13(9):1115-23. PubMed ID: 24992986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
    Watanabe M
    Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.
    Thomas MG; Redhead K; Lambert HP
    J Infect Dis; 1989 Feb; 159(2):211-8. PubMed ID: 2536779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.
    Davis LE; Burstyn DG; Manclark CR
    Pediatr Infect Dis; 1984; 3(5):448-51. PubMed ID: 6093068
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains.
    Watanabe M; Munoz JJ
    Microbiol Immunol; 1982; 26(10):965-9. PubMed ID: 6298581
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 13. The concept of pertussis as a toxin-mediated disease.
    Pittman M
    Pediatr Infect Dis; 1984; 3(5):467-86. PubMed ID: 6093069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies to pertussis toxin in whooping cough.
    Granström M; Granström G; Gillenius P; Askelöf P
    J Infect Dis; 1985 Apr; 151(4):646-9. PubMed ID: 2857752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The virulence factors of Bordetella pertussis: talented modulators of host immune response.
    Fedele G; Bianco M; Ausiello CM
    Arch Immunol Ther Exp (Warsz); 2013 Dec; 61(6):445-57. PubMed ID: 23955529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of acellular pertussis vaccines.
    Preston NW; Matthews RC
    Lancet; 1996 Mar; 347(9003):764. PubMed ID: 8602023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.